The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 12 July 2005, www.theannals.com, DOI 10.1345/aph.1E634.
The Annals of Pharmacotherapy: Vol. 39, No. 9, pp. 1566-1569. DOI 10.1345/aph.1E634
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bromley, J.
Right arrow Articles by Buckley, N. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bromley, J.
Right arrow Articles by Buckley, N. A

Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C

Jonathan Bromley, MBChB

Toxicology Registrar, Department of Clinical Pharmacology and Toxicology, The Canberra Hospital, Garran, Australia

Brett GM Hughes, BSc (Med) MBBS (Hons)

Medical Oncology Registrar, Department of Medical Oncology, The Canberra Hospital

David CS Leong, MBBS FRACP

Consultant Medical Oncologist, Department of Medical Oncology, The Canberra Hospital

Nicholas A Buckley, MD FRACP

Consultant Toxicologist and Clinical Pharmacologist, Department of Clinical Pharmacology and Toxicology, The Canberra Hospital

Reprints: Dr. Bromley, Department of Clinical Pharmacology and Toxicology, The Canberra Hospital, Yamba Dr., Garran, Australia, ACT 2606, fax 02 62813935, jonathan.bromley{at}act.gov.au

OBJECTIVE: To describe a case of severe accidental cyanide poisoning following a single ingestion of amygdalin with therapeutic intent.

CASE SUMMARY: A 68-year-old patient with cancer presented to the emergency department shortly after her first dose (3 g) of amygdalin with a reduced Glasgow Coma Score, seizures, and severe lactic acidosis requiring intubation and ventilation. The patient also ingested 4800 mg of vitamin C per day. She responded rapidly to hydroxocobalamin treatment. The adverse drug reaction was rated probable on the Naranjo probability scale.

DISCUSSION: Amygdalin and laetrile (a synthetic form of amygdalin) are commonly used as complementary or alternative medicine (CAM) for the treatment of cancer. Vitamin C is known to increase the in vitro conversion of amygdalin to cyanide and reduce body stores of cysteine, which is used to detoxify cyanide. Amygdalin has been used for decades by patients with cancer who are seeking alternative therapies, and severe reactions have not been reported with this dose. An interaction with vitamin C is a plausible explanation for this life-threatening response.

CONCLUSIONS: This case highlights the fact that CAMs can produce life-threatening toxicity. This case also adds a further note of caution, namely, the potential for serious interactions between CAMs, particularly where there is no tradition of concomitant use.

Key Words: amygdalin, cyanide, laetrile, vitamin C

Published Online, July 12, 2005. www.theannals.com, DOI 10.1345/aph.1E634


This article has been cited by other articles:


Home page
PediatricsHome page
R. J. Geller, C. Barthold, J. A. Saiers, and A. H. Hall
Pediatric Cyanide Poisoning: Causes, Manifestations, Management, and Unmet Needs
Pediatrics, November 1, 2006; 118(5): 2146 - 2158.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.